Natural compounds have shown significant potential in improving the metabolic dysregulation associated with T2DM and obesity by regulating glucose and lipid metabolism, alleviating oxidative stress, and enhancing insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.